R. Manfredini et al., ANTISENSE INHIBITION OF C-FES PROTOONCOGENE BLOCKS PMA-INDUCED MACROPHAGE DIFFERENTIATION IN HL60 AND IN FDC-P1 MAC-11 CELLS/, Blood, 89(1), 1997, pp. 135-145
To gain some insight into the role of c-fes in macrophage differentiat
ion, we have analyzed the ability of HL60 leukemic promyelocytic cells
and FDC-P1/MAC-11 murine myeloid precursor cells to differentiate in
response to phorbol esters after inhibition of c-fes function. Fes ina
ctivation has been obtained by using oligodeoxynucleotides (ODN) compl
ementary to the 5' region of c-fes mRNA and to 5' splice junctions of
c-fes primary transcript. After 5 days (d) in culture, in several sepa
rate experiments performed with different ODN preparations, a complete
inhibition of c-fes expression was observed in HL60 and in FDC-P1/MAC
-11 cells. No perturbation of cell growth was evident in our experimen
tal conditions in both cell lines after c-fes inhibition. Furthermore,
in HL60 cells lacking c-fes product, an almost complete downregulatio
n of the alpha 4 beta 1 fibronectin receptor occurred. However, in bot
h cell lines, the induction of macrophage differentiation by phorbol e
aters resulted in an almost complete maturation arrest as evaluated by
morphological, cytochemical, immunological criteria, and by the cytof
luorimetric cell cycle analysis. A loss of the adhesion capacity of bo
th myeloid cell lines, when compared to terminally differentated macro
phages, was also observed. These results suggest that HL60 and FDC-P1/
MAC-11 cells, when treated with phorbol 12-myristate 13-acetate, requi
re c-fes protein expression to activate the genetic program underlying
macrophage differentiation. (C) 1997 by The American Society of Hemat
ology.